Previous studies explored the use of urinary adiponectin for the screening or early detection of microvascular injury in diabetes mellitus [26, 35], and SLE [36], glomerular injury, and proteinuria in IgA nephropathy [37]. This evidence concerns the gene ADIPOQ and IgA glomerulonephritis.